Michael G. Kauffman serves as Executive at EPIX Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Michael G. Kauffman has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 23, 2008 involved transacting 60,025 shares valued at $0.
Michael G. Kauffman currently holds 169,127 shares of EPIX Pharmaceuticals, Inc. (EPIX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael G. Kauffman has been a net neutral trader of EPIX stock. They have purchased $0 and sold $0 worth of shares.
Michael G. Kauffman's most recent insider trade was on Jan 23, 2008, when they sold 60,025 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $3.08 |
| Discretionary |
| Jan 3, 2007 | EPIX | $49.5K | Option Exercise | 50,521 | $0.98 | Discretionary |
| Nov 3, 2006 | EPIX | $26.1K | Option Exercise | 26,672 | $0.98 | Discretionary |
| Aug 16, 2006 | EPIX | $0 | Award | 123,294 | $N/A | Discretionary |